nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—colon cancer	0.541	1	CbGaD
Rosiglitazone—SLCO1B1—Irinotecan—colon cancer	0.0687	0.192	CbGbCtD
Rosiglitazone—CYP2A6—Fluorouracil—colon cancer	0.0565	0.158	CbGbCtD
Rosiglitazone—ALB—Irinotecan—colon cancer	0.0376	0.105	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—colon cancer	0.0363	0.102	CbGbCtD
Rosiglitazone—ALB—Fluorouracil—colon cancer	0.0361	0.101	CbGbCtD
Rosiglitazone—CYP2C9—Capecitabine—colon cancer	0.0328	0.0919	CbGbCtD
Rosiglitazone—CYP2C8—Fluorouracil—colon cancer	0.0279	0.0781	CbGbCtD
Rosiglitazone—CYP1A2—Fluorouracil—colon cancer	0.0216	0.0605	CbGbCtD
Rosiglitazone—ALB—Methotrexate—colon cancer	0.0199	0.0558	CbGbCtD
Rosiglitazone—CYP2C9—Fluorouracil—colon cancer	0.0194	0.0545	CbGbCtD
Rosiglitazone—PPARG—Topotecan—Irinotecan—colon cancer	0.00342	1	CbGdCrCtD
Rosiglitazone—Pioglitazone—PPARG—colon cancer	0.00323	1	CrCbGaD
Rosiglitazone—Ischaemia—Irinotecan—colon cancer	0.00227	0.0414	CcSEcCtD
Rosiglitazone—PPARG—endothelium—colon cancer	0.00212	0.057	CbGeAlD
Rosiglitazone—ACSL4—renal system—colon cancer	0.00196	0.0527	CbGeAlD
Rosiglitazone—PPARG—blood vessel—colon cancer	0.00195	0.0526	CbGeAlD
Rosiglitazone—ALB—gall bladder—colon cancer	0.00172	0.0464	CbGeAlD
Rosiglitazone—ACSL4—digestive system—colon cancer	0.00161	0.0433	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—colon cancer	0.00148	0.0399	CbGeAlD
Rosiglitazone—ACSL4—vagina—colon cancer	0.00142	0.0382	CbGeAlD
Rosiglitazone—ACSL4—liver—colon cancer	0.0012	0.0322	CbGeAlD
Rosiglitazone—PPARG—embryo—colon cancer	0.00116	0.0314	CbGeAlD
Rosiglitazone—PTGS1—endothelium—colon cancer	0.00113	0.0305	CbGeAlD
Rosiglitazone—Haematocrit decreased—Methotrexate—colon cancer	0.00111	0.0202	CcSEcCtD
Rosiglitazone—PTGS1—blood vessel—colon cancer	0.00104	0.0281	CbGeAlD
Rosiglitazone—Myocardial ischaemia—Irinotecan—colon cancer	0.00103	0.0188	CcSEcCtD
Rosiglitazone—SLCO1B1—renal system—colon cancer	0.00102	0.0275	CbGeAlD
Rosiglitazone—Myocardial ischaemia—Fluorouracil—colon cancer	0.000985	0.018	CcSEcCtD
Rosiglitazone—Hypertriglyceridaemia—Capecitabine—colon cancer	0.000963	0.0176	CcSEcCtD
Rosiglitazone—PPARG—epithelium—colon cancer	0.00095	0.0256	CbGeAlD
Rosiglitazone—Visual acuity reduced—Capecitabine—colon cancer	0.00093	0.017	CcSEcCtD
Rosiglitazone—ACSL4—lymph node—colon cancer	0.000918	0.0247	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—colon cancer	0.000916	0.0247	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Irinotecan—colon cancer	0.000909	0.0166	CcSEcCtD
Rosiglitazone—PPARG—renal system—colon cancer	0.000881	0.0237	CbGeAlD
Rosiglitazone—Blood triglycerides increased—Capecitabine—colon cancer	0.000844	0.0154	CcSEcCtD
Rosiglitazone—SLCO1B1—digestive system—colon cancer	0.000838	0.0226	CbGeAlD
Rosiglitazone—CYP2A6—vagina—colon cancer	0.00075	0.0202	CbGeAlD
Rosiglitazone—PPARG—lymphoid tissue—colon cancer	0.000732	0.0197	CbGeAlD
Rosiglitazone—PPARG—digestive system—colon cancer	0.000723	0.0195	CbGeAlD
Rosiglitazone—Pleural effusion—Capecitabine—colon cancer	0.000722	0.0132	CcSEcCtD
Rosiglitazone—Fracture—Methotrexate—colon cancer	0.000709	0.0129	CcSEcCtD
Rosiglitazone—Multiple fractures—Methotrexate—colon cancer	0.000709	0.0129	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Capecitabine—colon cancer	0.000688	0.0126	CcSEcCtD
Rosiglitazone—Hepatic failure—Vincristine—colon cancer	0.000686	0.0125	CcSEcCtD
Rosiglitazone—PPARG—bone marrow—colon cancer	0.000666	0.0179	CbGeAlD
Rosiglitazone—PPARG—vagina—colon cancer	0.000638	0.0172	CbGeAlD
Rosiglitazone—CYP2A6—liver—colon cancer	0.000633	0.017	CbGeAlD
Rosiglitazone—SLCO1B1—liver—colon cancer	0.000624	0.0168	CbGeAlD
Rosiglitazone—Cerebrovascular accident—Irinotecan—colon cancer	0.000612	0.0112	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Capecitabine—colon cancer	0.000608	0.0111	CcSEcCtD
Rosiglitazone—Cardiac failure—Fluorouracil—colon cancer	0.000589	0.0108	CcSEcCtD
Rosiglitazone—CYP2C8—renal system—colon cancer	0.000581	0.0156	CbGeAlD
Rosiglitazone—CYP2C19—digestive system—colon cancer	0.000546	0.0147	CbGeAlD
Rosiglitazone—CYP1A2—renal system—colon cancer	0.000544	0.0146	CbGeAlD
Rosiglitazone—PPARG—liver—colon cancer	0.000539	0.0145	CbGeAlD
Rosiglitazone—Pleural effusion—Methotrexate—colon cancer	0.000538	0.00983	CcSEcCtD
Rosiglitazone—Fluid retention—Capecitabine—colon cancer	0.000525	0.0096	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Fluorouracil—colon cancer	0.000514	0.00939	CcSEcCtD
Rosiglitazone—PTGS1—epithelium—colon cancer	0.000508	0.0137	CbGeAlD
Rosiglitazone—ALB—liver—colon cancer	0.000505	0.0136	CbGeAlD
Rosiglitazone—PTGS1—smooth muscle tissue—colon cancer	0.00049	0.0132	CbGeAlD
Rosiglitazone—CYP2C19—vagina—colon cancer	0.000482	0.013	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Irinotecan—colon cancer	0.000482	0.00881	CcSEcCtD
Rosiglitazone—PTGS1—renal system—colon cancer	0.000471	0.0127	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Vincristine—colon cancer	0.000468	0.00855	CcSEcCtD
Rosiglitazone—Myocardial infarction—Vincristine—colon cancer	0.000465	0.0085	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Capecitabine—colon cancer	0.000462	0.00844	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000462	0.00843	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Capecitabine—colon cancer	0.000459	0.0084	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Irinotecan—colon cancer	0.000456	0.00833	CcSEcCtD
Rosiglitazone—Myocardial infarction—Irinotecan—colon cancer	0.000453	0.00828	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000453	0.00828	CcSEcCtD
Rosiglitazone—Hepatic failure—Capecitabine—colon cancer	0.000447	0.00817	CcSEcCtD
Rosiglitazone—CYP1A2—digestive system—colon cancer	0.000446	0.012	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000437	0.00798	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—colon cancer	0.000435	0.00796	CcSEcCtD
Rosiglitazone—Myocardial infarction—Fluorouracil—colon cancer	0.000434	0.00793	CcSEcCtD
Rosiglitazone—Increased appetite—Capecitabine—colon cancer	0.000427	0.00781	CcSEcCtD
Rosiglitazone—CYP2C9—digestive system—colon cancer	0.000423	0.0114	CbGeAlD
Rosiglitazone—CYP2C8—vagina—colon cancer	0.000421	0.0113	CbGeAlD
Rosiglitazone—Connective tissue disorder—Vincristine—colon cancer	0.000419	0.00765	CcSEcCtD
Rosiglitazone—Sinusitis—Fluorouracil—colon cancer	0.000415	0.00759	CcSEcCtD
Rosiglitazone—PPARG—lymph node—colon cancer	0.000413	0.0111	CbGeAlD
Rosiglitazone—Cardiac failure—Capecitabine—colon cancer	0.000411	0.00752	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Capecitabine—colon cancer	0.00041	0.00749	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Irinotecan—colon cancer	0.000408	0.00745	CcSEcCtD
Rosiglitazone—CYP2C19—liver—colon cancer	0.000407	0.011	CbGeAlD
Rosiglitazone—Cardiac disorder—Vincristine—colon cancer	0.000396	0.00723	CcSEcCtD
Rosiglitazone—ALB—lymph node—colon cancer	0.000387	0.0104	CbGeAlD
Rosiglitazone—CYP2D6—renal system—colon cancer	0.000387	0.0104	CbGeAlD
Rosiglitazone—PTGS1—digestive system—colon cancer	0.000386	0.0104	CbGeAlD
Rosiglitazone—Cardiac disorder—Irinotecan—colon cancer	0.000385	0.00704	CcSEcCtD
Rosiglitazone—Immune system disorder—Irinotecan—colon cancer	0.000375	0.00685	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—colon cancer	0.000367	0.0067	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Capecitabine—colon cancer	0.000359	0.00656	CcSEcCtD
Rosiglitazone—Back pain—Vincristine—colon cancer	0.000359	0.00656	CcSEcCtD
Rosiglitazone—CYP2C8—liver—colon cancer	0.000355	0.00956	CbGeAlD
Rosiglitazone—Back pain—Irinotecan—colon cancer	0.000349	0.00639	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—colon cancer	0.000344	0.00628	CcSEcCtD
Rosiglitazone—Anaemia—Vincristine—colon cancer	0.000343	0.00627	CcSEcCtD
Rosiglitazone—PTGS1—vagina—colon cancer	0.000341	0.00919	CbGeAlD
Rosiglitazone—Anaemia—Irinotecan—colon cancer	0.000334	0.0061	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—colon cancer	0.000333	0.00608	CcSEcCtD
Rosiglitazone—CYP1A2—liver—colon cancer	0.000332	0.00895	CbGeAlD
Rosiglitazone—Leukopenia—Vincristine—colon cancer	0.000332	0.00607	CcSEcCtD
Rosiglitazone—Leukopenia—Irinotecan—colon cancer	0.000323	0.00591	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Capecitabine—colon cancer	0.000323	0.00589	CcSEcCtD
Rosiglitazone—Hypertension—Vincristine—colon cancer	0.00032	0.00585	CcSEcCtD
Rosiglitazone—Anaemia—Fluorouracil—colon cancer	0.00032	0.00584	CcSEcCtD
Rosiglitazone—CYP2D6—digestive system—colon cancer	0.000318	0.00855	CbGeAlD
Rosiglitazone—Myalgia—Vincristine—colon cancer	0.000316	0.00577	CcSEcCtD
Rosiglitazone—Weight increased—Capecitabine—colon cancer	0.000316	0.00577	CcSEcCtD
Rosiglitazone—CYP2C9—liver—colon cancer	0.000315	0.00849	CbGeAlD
Rosiglitazone—Hyperglycaemia—Capecitabine—colon cancer	0.000313	0.00572	CcSEcCtD
Rosiglitazone—Hypertension—Irinotecan—colon cancer	0.000312	0.0057	CcSEcCtD
Rosiglitazone—Leukopenia—Fluorouracil—colon cancer	0.00031	0.00566	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000307	0.00561	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Capecitabine—colon cancer	0.000305	0.00557	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—colon cancer	0.000305	0.00557	CcSEcCtD
Rosiglitazone—Myocardial infarction—Capecitabine—colon cancer	0.000303	0.00554	CcSEcCtD
Rosiglitazone—Oedema—Vincristine—colon cancer	0.000303	0.00553	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Vincristine—colon cancer	0.000303	0.00553	CcSEcCtD
Rosiglitazone—Infection—Vincristine—colon cancer	0.000301	0.0055	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vincristine—colon cancer	0.000297	0.00543	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Vincristine—colon cancer	0.000296	0.00542	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Irinotecan—colon cancer	0.000295	0.00539	CcSEcCtD
Rosiglitazone—Oedema—Irinotecan—colon cancer	0.000295	0.00539	CcSEcCtD
Rosiglitazone—Myalgia—Fluorouracil—colon cancer	0.000295	0.00538	CcSEcCtD
Rosiglitazone—Infection—Irinotecan—colon cancer	0.000293	0.00535	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Capecitabine—colon cancer	0.000293	0.00535	CcSEcCtD
Rosiglitazone—Nervous system disorder—Irinotecan—colon cancer	0.000289	0.00528	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Irinotecan—colon cancer	0.000289	0.00528	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Fluorouracil—colon cancer	0.000282	0.00516	CcSEcCtD
Rosiglitazone—Oedema—Fluorouracil—colon cancer	0.000282	0.00516	CcSEcCtD
Rosiglitazone—Infection—Fluorouracil—colon cancer	0.000281	0.00513	CcSEcCtD
Rosiglitazone—Hepatitis—Capecitabine—colon cancer	0.000278	0.00508	CcSEcCtD
Rosiglitazone—Nervous system disorder—Fluorouracil—colon cancer	0.000277	0.00506	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Fluorouracil—colon cancer	0.000277	0.00505	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000276	0.00504	CcSEcCtD
Rosiglitazone—Oedema peripheral—Capecitabine—colon cancer	0.000274	0.005	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Capecitabine—colon cancer	0.000273	0.00499	CcSEcCtD
Rosiglitazone—Erythema multiforme—Capecitabine—colon cancer	0.000263	0.0048	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vincristine—colon cancer	0.000261	0.00478	CcSEcCtD
Rosiglitazone—Fatigue—Vincristine—colon cancer	0.000261	0.00477	CcSEcCtD
Rosiglitazone—Eye disorder—Capecitabine—colon cancer	0.00026	0.00474	CcSEcCtD
Rosiglitazone—Constipation—Vincristine—colon cancer	0.000259	0.00473	CcSEcCtD
Rosiglitazone—Cardiac disorder—Capecitabine—colon cancer	0.000258	0.00471	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000257	0.0047	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000255	0.00465	CcSEcCtD
Rosiglitazone—Fatigue—Irinotecan—colon cancer	0.000254	0.00465	CcSEcCtD
Rosiglitazone—Constipation—Irinotecan—colon cancer	0.000252	0.00461	CcSEcCtD
Rosiglitazone—Immune system disorder—Capecitabine—colon cancer	0.000251	0.00459	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000244	0.00446	CcSEcCtD
Rosiglitazone—Malnutrition—Capecitabine—colon cancer	0.000242	0.00442	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—colon cancer	0.00024	0.00439	CcSEcCtD
Rosiglitazone—CYP2D6—liver—colon cancer	0.000237	0.00637	CbGeAlD
Rosiglitazone—Back pain—Capecitabine—colon cancer	0.000234	0.00427	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000228	0.00417	CcSEcCtD
Rosiglitazone—Urticaria—Fluorouracil—colon cancer	0.000224	0.0041	CcSEcCtD
Rosiglitazone—Anaemia—Capecitabine—colon cancer	0.000224	0.00408	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—colon cancer	0.000221	0.00594	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Methotrexate—colon cancer	0.000218	0.00398	CcSEcCtD
Rosiglitazone—Asthenia—Vincristine—colon cancer	0.000217	0.00397	CcSEcCtD
Rosiglitazone—Leukopenia—Capecitabine—colon cancer	0.000216	0.00396	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—colon cancer	0.000212	0.00387	CcSEcCtD
Rosiglitazone—Hypertension—Capecitabine—colon cancer	0.000209	0.00382	CcSEcCtD
Rosiglitazone—Diarrhoea—Vincristine—colon cancer	0.000207	0.00379	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—colon cancer	0.000207	0.00378	CcSEcCtD
Rosiglitazone—Arthralgia—Capecitabine—colon cancer	0.000206	0.00376	CcSEcCtD
Rosiglitazone—Myalgia—Capecitabine—colon cancer	0.000206	0.00376	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—colon cancer	0.000202	0.00369	CcSEcCtD
Rosiglitazone—Dizziness—Vincristine—colon cancer	0.0002	0.00366	CcSEcCtD
Rosiglitazone—Pruritus—Fluorouracil—colon cancer	0.0002	0.00365	CcSEcCtD
Rosiglitazone—Oedema—Capecitabine—colon cancer	0.000197	0.00361	CcSEcCtD
Rosiglitazone—Infection—Capecitabine—colon cancer	0.000196	0.00358	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—colon cancer	0.000196	0.00357	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—colon cancer	0.000195	0.00356	CcSEcCtD
Rosiglitazone—Nervous system disorder—Capecitabine—colon cancer	0.000194	0.00354	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—colon cancer	0.000193	0.00353	CcSEcCtD
Rosiglitazone—Diarrhoea—Fluorouracil—colon cancer	0.000193	0.00353	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Capecitabine—colon cancer	0.000193	0.00353	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—colon cancer	0.000192	0.00351	CcSEcCtD
Rosiglitazone—Rash—Vincristine—colon cancer	0.000191	0.00349	CcSEcCtD
Rosiglitazone—Dermatitis—Vincristine—colon cancer	0.000191	0.00349	CcSEcCtD
Rosiglitazone—Headache—Vincristine—colon cancer	0.00019	0.00347	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—colon cancer	0.000187	0.00341	CcSEcCtD
Rosiglitazone—Dizziness—Fluorouracil—colon cancer	0.000187	0.00341	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—colon cancer	0.000186	0.0034	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—colon cancer	0.000186	0.00339	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—colon cancer	0.000185	0.00338	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—colon cancer	0.00018	0.00329	CcSEcCtD
Rosiglitazone—Nausea—Vincristine—colon cancer	0.00018	0.00329	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00018	0.00329	CcSEcCtD
Rosiglitazone—Rash—Fluorouracil—colon cancer	0.000178	0.00325	CcSEcCtD
Rosiglitazone—Dermatitis—Fluorouracil—colon cancer	0.000178	0.00325	CcSEcCtD
Rosiglitazone—Headache—Fluorouracil—colon cancer	0.000177	0.00323	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—colon cancer	0.000175	0.0032	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—colon cancer	0.000174	0.00318	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00017	0.00311	CcSEcCtD
Rosiglitazone—Fatigue—Capecitabine—colon cancer	0.00017	0.00311	CcSEcCtD
Rosiglitazone—Constipation—Capecitabine—colon cancer	0.000169	0.00308	CcSEcCtD
Rosiglitazone—Nausea—Fluorouracil—colon cancer	0.000168	0.00307	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—colon cancer	0.000166	0.00304	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—colon cancer	0.000161	0.00294	CcSEcCtD
Rosiglitazone—Urticaria—Capecitabine—colon cancer	0.000157	0.00287	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—colon cancer	0.000153	0.0028	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—colon cancer	0.000153	0.0028	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—colon cancer	0.000147	0.00268	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—colon cancer	0.000146	0.00267	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—colon cancer	0.000144	0.00263	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—colon cancer	0.000144	0.00263	CcSEcCtD
Rosiglitazone—Asthenia—Capecitabine—colon cancer	0.000142	0.00259	CcSEcCtD
Rosiglitazone—Pruritus—Capecitabine—colon cancer	0.00014	0.00255	CcSEcCtD
Rosiglitazone—Diarrhoea—Capecitabine—colon cancer	0.000135	0.00247	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000134	0.00245	CcSEcCtD
Rosiglitazone—Dizziness—Capecitabine—colon cancer	0.000131	0.00238	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000127	0.00232	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—colon cancer	0.000127	0.00231	CcSEcCtD
Rosiglitazone—Rash—Capecitabine—colon cancer	0.000124	0.00227	CcSEcCtD
Rosiglitazone—Dermatitis—Capecitabine—colon cancer	0.000124	0.00227	CcSEcCtD
Rosiglitazone—Headache—Capecitabine—colon cancer	0.000124	0.00226	CcSEcCtD
Rosiglitazone—Nausea—Capecitabine—colon cancer	0.000117	0.00214	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—colon cancer	0.000117	0.00213	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—colon cancer	0.000105	0.00193	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—colon cancer	0.000104	0.0019	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—colon cancer	0.000101	0.00184	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—colon cancer	9.72e-05	0.00178	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—colon cancer	9.26e-05	0.00169	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—colon cancer	9.26e-05	0.00169	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—colon cancer	9.2e-05	0.00168	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—colon cancer	8.73e-05	0.00159	CcSEcCtD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	4.94e-05	0.0125	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	4.83e-05	0.0122	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	4.74e-05	0.012	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ODC1—colon cancer	4.66e-05	0.0118	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CHST5—colon cancer	4.66e-05	0.0118	CbGpPWpGaD
Rosiglitazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	4.22e-05	0.0107	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—APC—colon cancer	4.15e-05	0.0105	CbGpPWpGaD
Rosiglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	4.1e-05	0.0104	CbGpPWpGaD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	3.97e-05	0.01	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	3.73e-05	0.00946	CbGpPWpGaD
Rosiglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.43e-05	0.00869	CbGpPWpGaD
Rosiglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	3.43e-05	0.00868	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	3.33e-05	0.00844	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—colon cancer	3.25e-05	0.00824	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.16e-05	0.00801	CbGpPWpGaD
Rosiglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.13e-05	0.00792	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	3.07e-05	0.00777	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	3.04e-05	0.0077	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	3.02e-05	0.00765	CbGpPWpGaD
Rosiglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	2.98e-05	0.00755	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—CCND1—colon cancer	2.85e-05	0.00721	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—colon cancer	2.82e-05	0.00714	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	2.6e-05	0.00658	CbGpPWpGaD
Rosiglitazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	2.54e-05	0.00645	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CA7—colon cancer	2.36e-05	0.00598	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CCND1—colon cancer	2.35e-05	0.00596	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—MYC—colon cancer	2.28e-05	0.00579	CbGpPWpGaD
Rosiglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	2.28e-05	0.00577	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CDKN1A—colon cancer	2.28e-05	0.00577	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—EP300—colon cancer	2.17e-05	0.00549	CbGpPWpGaD
Rosiglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.07e-05	0.00525	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—EP300—colon cancer	2.07e-05	0.00523	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.92e-05	0.00488	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TYMS—colon cancer	1.92e-05	0.00486	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	1.91e-05	0.00485	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	1.89e-05	0.00479	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CA7—colon cancer	1.86e-05	0.00471	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—DCC—colon cancer	1.81e-05	0.00458	CbGpPWpGaD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—TP53—colon cancer	1.79e-05	0.00453	CbGpPWpGaD
Rosiglitazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	1.77e-05	0.00449	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	1.66e-05	0.00422	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CA7—colon cancer	1.65e-05	0.00419	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—HNF4A—colon cancer	1.62e-05	0.0041	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—AKT1—colon cancer	1.58e-05	0.00401	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CA7—colon cancer	1.56e-05	0.00396	CbGpPWpGaD
Rosiglitazone—PPARG—SREBP signalling—PIK3CA—colon cancer	1.55e-05	0.00392	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HNF4A—colon cancer	1.52e-05	0.00386	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.51e-05	0.00384	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	1.47e-05	0.00373	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	1.45e-05	0.00367	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—EP300—colon cancer	1.44e-05	0.00365	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CHST5—colon cancer	1.43e-05	0.00362	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ODC1—colon cancer	1.43e-05	0.00362	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.41e-05	0.00357	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—CTNNB1—colon cancer	1.35e-05	0.00343	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—CDKN1A—colon cancer	1.32e-05	0.00335	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	1.31e-05	0.00333	CbGpPWpGaD
Rosiglitazone—PPARG—SREBP signalling—AKT1—colon cancer	1.26e-05	0.0032	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.26e-05	0.00319	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ABCB1—colon cancer	1.23e-05	0.00312	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TYMS—colon cancer	1.21e-05	0.00307	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	1.2e-05	0.00303	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ODC1—colon cancer	1.13e-05	0.00285	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CHST5—colon cancer	1.13e-05	0.00285	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TGFB1—colon cancer	1.09e-05	0.00277	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	1.09e-05	0.00277	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CA7—colon cancer	1.07e-05	0.00271	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CA7—colon cancer	1.06e-05	0.00269	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	1.02e-05	0.00259	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CHST5—colon cancer	1e-05	0.00254	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ODC1—colon cancer	1e-05	0.00254	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	9.7e-06	0.00246	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	9.56e-06	0.00242	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CA7—colon cancer	9.54e-06	0.00242	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CHST5—colon cancer	9.48e-06	0.0024	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ODC1—colon cancer	9.48e-06	0.0024	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.31e-06	0.00236	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	9.31e-06	0.00236	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	9.1e-06	0.0023	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	9.1e-06	0.0023	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—EP300—colon cancer	8.88e-06	0.00225	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	8.85e-06	0.00224	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	8.85e-06	0.00224	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CA7—colon cancer	8.77e-06	0.00222	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CA7—colon cancer	8.7e-06	0.0022	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	8.61e-06	0.00218	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PPARG—colon cancer	8.57e-06	0.00217	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	8.51e-06	0.00216	CbGpPWpGaD
Rosiglitazone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	8.14e-06	0.00206	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	7.93e-06	0.00201	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—VEGFA—colon cancer	7.91e-06	0.002	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	7.91e-06	0.002	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—HNF4A—colon cancer	7.79e-06	0.00197	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	7.75e-06	0.00196	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	7.75e-06	0.00196	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	7.54e-06	0.00191	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA7—colon cancer	7.43e-06	0.00188	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	7.32e-06	0.00186	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—TGFB1—colon cancer	7.26e-06	0.00184	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—colon cancer	6.97e-06	0.00177	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	6.92e-06	0.00175	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTGS2—colon cancer	6.74e-06	0.00171	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—TGFB1—colon cancer	6.61e-06	0.00167	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CHST5—colon cancer	6.47e-06	0.00164	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ODC1—colon cancer	6.47e-06	0.00164	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ODC1—colon cancer	6.44e-06	0.00163	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CHST5—colon cancer	6.44e-06	0.00163	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—colon cancer	6.36e-06	0.00161	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	6.36e-06	0.00161	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	6.23e-06	0.00158	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CHST5—colon cancer	5.78e-06	0.00146	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ODC1—colon cancer	5.78e-06	0.00146	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—EP300—colon cancer	5.61e-06	0.00142	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ODC1—colon cancer	5.31e-06	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CHST5—colon cancer	5.31e-06	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ODC1—colon cancer	5.27e-06	0.00133	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CHST5—colon cancer	5.27e-06	0.00133	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CTNNB1—colon cancer	4.66e-06	0.00118	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.65e-06	0.00118	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.65e-06	0.00118	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CHST5—colon cancer	4.5e-06	0.00114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ODC1—colon cancer	4.5e-06	0.00114	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EP300—colon cancer	4.33e-06	0.0011	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—SRC—colon cancer	4.21e-06	0.00107	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PIK3CA—colon cancer	4.15e-06	0.00105	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.14e-06	0.00105	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VEGFA—colon cancer	4.1e-06	0.00104	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NRAS—colon cancer	4.05e-06	0.00103	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—colon cancer	4.01e-06	0.00101	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.86e-06	0.000979	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ABCB1—colon cancer	3.78e-06	0.000958	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—colon cancer	3.76e-06	0.000953	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TYMS—colon cancer	3.71e-06	0.000941	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—colon cancer	3.69e-06	0.000934	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.66e-06	0.000927	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	3.63e-06	0.00092	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	3.6e-06	0.000913	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.51e-06	0.000889	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KRAS—colon cancer	3.48e-06	0.000883	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—colon cancer	3.39e-06	0.000859	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.25e-06	0.000825	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.22e-06	0.000816	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.04e-06	0.000771	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—colon cancer	2.98e-06	0.000754	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—colon cancer	2.96e-06	0.00075	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TYMS—colon cancer	2.92e-06	0.000741	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.86e-06	0.000724	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.74e-06	0.000694	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.71e-06	0.000686	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.67e-06	0.000677	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.66e-06	0.000673	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—colon cancer	2.65e-06	0.000671	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—colon cancer	2.61e-06	0.000662	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TYMS—colon cancer	2.6e-06	0.000659	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—colon cancer	2.5e-06	0.000635	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TYMS—colon cancer	2.46e-06	0.000623	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.39e-06	0.000604	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.25e-06	0.00057	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.24e-06	0.000567	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.18e-06	0.000551	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.1e-06	0.000533	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.09e-06	0.00053	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—colon cancer	2.07e-06	0.000525	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—colon cancer	2.07e-06	0.000524	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2e-06	0.000507	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—colon cancer	1.93e-06	0.000489	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EP300—colon cancer	1.91e-06	0.000484	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.88e-06	0.000475	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.86e-06	0.000471	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—colon cancer	1.86e-06	0.000471	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—colon cancer	1.84e-06	0.000467	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—colon cancer	1.81e-06	0.000458	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—colon cancer	1.79e-06	0.000453	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.75e-06	0.000443	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—colon cancer	1.74e-06	0.000441	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.74e-06	0.00044	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—EP300—colon cancer	1.72e-06	0.000436	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.71e-06	0.000434	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—colon cancer	1.71e-06	0.000433	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—colon cancer	1.7e-06	0.000431	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMS—colon cancer	1.68e-06	0.000426	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMS—colon cancer	1.67e-06	0.000423	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—colon cancer	1.66e-06	0.000421	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—colon cancer	1.63e-06	0.000413	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.56e-06	0.000395	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—colon cancer	1.54e-06	0.00039	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—colon cancer	1.53e-06	0.000387	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMS—colon cancer	1.5e-06	0.00038	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.46e-06	0.00037	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—colon cancer	1.45e-06	0.000367	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.42e-06	0.000361	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—colon cancer	1.41e-06	0.000358	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—colon cancer	1.4e-06	0.000356	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—colon cancer	1.39e-06	0.000353	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMS—colon cancer	1.38e-06	0.000349	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—colon cancer	1.37e-06	0.000347	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMS—colon cancer	1.37e-06	0.000346	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—colon cancer	1.37e-06	0.000346	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—EP300—colon cancer	1.36e-06	0.000343	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—colon cancer	1.34e-06	0.000339	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—colon cancer	1.31e-06	0.000331	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.29e-06	0.000328	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.29e-06	0.000326	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—colon cancer	1.27e-06	0.000323	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.22e-06	0.000308	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—EP300—colon cancer	1.21e-06	0.000305	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—colon cancer	1.19e-06	0.000302	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—colon cancer	1.19e-06	0.000301	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—colon cancer	1.18e-06	0.0003	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMS—colon cancer	1.17e-06	0.000296	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.15e-06	0.000293	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—colon cancer	1.15e-06	0.000292	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—EP300—colon cancer	1.14e-06	0.000289	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—colon cancer	1.06e-06	0.000269	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.05e-06	0.000267	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—colon cancer	1.04e-06	0.000263	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—colon cancer	1e-06	0.000254	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—colon cancer	9.77e-07	0.000248	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—colon cancer	9.69e-07	0.000245	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—colon cancer	9.36e-07	0.000237	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—colon cancer	9.31e-07	0.000236	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9e-07	0.000228	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—colon cancer	8.92e-07	0.000226	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—colon cancer	8.43e-07	0.000214	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—colon cancer	8.36e-07	0.000212	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—colon cancer	8.28e-07	0.00021	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—colon cancer	8.19e-07	0.000207	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—EP300—colon cancer	7.79e-07	0.000197	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—EP300—colon cancer	7.74e-07	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—colon cancer	7.69e-07	0.000195	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—colon cancer	7.62e-07	0.000193	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—colon cancer	7.29e-07	0.000185	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—EP300—colon cancer	6.95e-07	0.000176	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—colon cancer	6.89e-07	0.000175	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—colon cancer	6.51e-07	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—EP300—colon cancer	6.39e-07	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—EP300—colon cancer	6.34e-07	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—colon cancer	5.76e-07	0.000146	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—colon cancer	5.73e-07	0.000145	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—EP300—colon cancer	5.42e-07	0.000137	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—colon cancer	5.14e-07	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—colon cancer	4.73e-07	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—colon cancer	4.71e-07	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—colon cancer	4.69e-07	0.000119	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—colon cancer	4.68e-07	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—colon cancer	4.2e-07	0.000106	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—colon cancer	4.01e-07	0.000102	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—colon cancer	3.86e-07	9.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—colon cancer	3.83e-07	9.7e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—colon cancer	3.27e-07	8.29e-05	CbGpPWpGaD
